Document is current
Any future updates will be listed below
-
Authors
Zhang, Shengnan
Zhang, Huifei
Wei, Xinhua
Fang, Zibing
Zhang, Yuan
Lv, Yudan
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2022ZD0210500)
Jilin Provincial science and technology Fund (20210402022GH)
Jilin Natural Science Fund (YDZJ202201ZYTS543)
- License Information
-
More Information
Article History
Received: 14 November 2023
Accepted: 23 June 2025
First Online: 17 July 2025
Declarations
:
: Ethics committee approval was obtained from the Ethics Committee of the First hospital of Jilin University (23K044-001). This study was registered in the Chinese Clinical Trial Registry with Portal Number ChiCTR2300073223 (04/07/2023). This study respects the life, health, dignity, self-determination, privacy and confidentiality of the subjects’ personal information of all participants. All methods were carried out in accordance with the guidelines and provisions of the Declaration of Helsinki. The purpose and requirements of the study were explained to all patients, and all patients signed written informed consent before the start of the trial.
: Not applicable.
: The authors declare no competing interests.
